AIDS and AIDS related infections Clinical Trials

A listing of AIDS and AIDS related infections medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Birmingham Alabama 35294

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

California

UPDATED

Bakersfield California 93301

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Long Beach California 90806

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

UPDATED

Long Beach California 90813

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Los Angeles California 90069

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Los Angeles California 90027

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

View More ▼

UPDATED

Los Angeles California 90069

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Sacramento California 95825

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

San Francisco California 94109

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

San Francisco California 94109

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

San Francisco California 94110

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

San Leandro California 94577

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Aurora Colorado 80045

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

UPDATED

Denver Colorado 80209

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

District of Columbia

UPDATED

Washington District of Columbia 20005

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Washington District of Columbia 20852

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

UPDATED

Washington District of Columbia 20037

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Washington District of Columbia 20009

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

Florida

UPDATED

Fort Lauderdale Florida 33316

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Fort Pierce Florida 34982

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Fort Pierce Florida 34982

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Miami Florida 33136

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Miami Florida 33133

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

View More ▼

UPDATED

Orlando Florida 32803

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Tampa Florida 33620

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

UPDATED

Vero Beach Florida 32960-6571

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

West Palm Beach Florida 33401

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

Georgia

UPDATED

Atlanta Georgia 30308

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

UPDATED

Decatur Georgia 30033

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Savannah Georgia 31401

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

Illinois

UPDATED

Chicago Illinois 60612-3833

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

Massachusetts

UPDATED

Boston Massachusetts 02118

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

Michigan

UPDATED

Berkley Michigan 48072

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

Missouri

UPDATED

St. Louis Missouri 63139

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

Nebraska

UPDATED

Omaha Nebraska 68198

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

New Jersey

UPDATED

Hillsborough New Jersey 08844

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

New York

UPDATED

New York New York 10016

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

UPDATED

Syracuse New York 13210

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

North Carolina

UPDATED

Chapel Hills North Carolina 27599

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Charlotte North Carolina 28209

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

Ohio

UPDATED

Cincinnati Ohio 45267-0405

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

Tennessee

UPDATED

Memphis Tennessee 38105

A Phase 2/Phase 3 clinical study for patients with Acquired Immune Deficiency Syndrome (AIDS) or HIV Infections

Texas

UPDATED

Austin Texas 78705

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Austin Texas 78705

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Dallas Texas 75246

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

UPDATED

Dallas Texas 75246

A Phase 3 clinical study for patients with Infection, Human Immunodeficiency Virus

UPDATED

Fort Worth Texas 76104

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus

View More ▼

UPDATED

Houston Texas 77098

A clinical trial to evaluate treatments using Dolutegravir (DTG), Lamivudine (3TC) and Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC) for patients with Infection, Human Immunodeficiency Virus